Neuronal Signaling

Items 251-300 of 576

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. Amyloid b-Peptide (12-28) (human), amyloid b-peptide fragment; minimum section required to bind to brain proteins.
  2. Amyloid b-Peptide (1-40) (human) is a peptide processed from the amyloid precursor protein (APP).
  3. Amyloid b-Peptide (1-43) (human), amyloid β peptide fragment. Highly toxic, showing higher neurotoxicity compared to Aβ40 and Aβ42.
  4. Beta-amyloid (1-11) (Abeta) is a peptide with the sequence H-{Asp}{Ala}{Glu}{Phe}{Arg}{His}{Asp}{Ser}{Gly}{Tyr}{Glu}-OH,which is processed from the Amyloid precursor protein.
  5. Beta-amyloid protein (A beta), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP), is also the principal component of amyloid.
  6. P2Y12 receptor antagonist

    AZD1283 is a potent antagonist of the P2Y12 receptor with EC50 of 3.0 ug/kg/min, TI >10; with binding IC50 of 11 nM.
  7. glutamate receptors agonist

    (S)-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA).
  8. Glucocerebroside synthase inhibitor

    Commonly used as the tartrate salt, Eliglustat is believed to work by inhibition of glucosylceramide synthase.
  9. M3 receptors inhibitor

    Imidafenacin is a potent and selective inhibitor of M3 receptors with Kb of 0.317 nM; less potent for M2 receptors(IC50=4.13 nM).
  10. NMDA/glycine receptor antagonist

    L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,
  11. NMDA receptors Potentiator

    CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.
  12. anti-cancer agent

    Ginsenoside Rc, isolated from Panax ginseng, may exert various activities including anti-cancer, anti-inflammatory, antiobesity, and anti-diabetic effects.
  13. hepatoprotective agent

    Gardenoside is a natural compound found in Gardenia fruits, with hepatoprotective properties. Gardenoside suppresses the pain of chronic constriction injury by regulating the P2X3 and P2X7 receptors. Gardenoside has an inhibitory effect on free fatty acids (FFA)-induced cellular steatosis.
  14. AChE inhibitor

    Acotiamide is a drug approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia.
  15. NMDA antagonist

    CGS 19755 (cis-4-phosphonomethyl-2-piperidine carboxylic acid) was found to be a potent, stereospecific inhibitor of N-methyl-D-aspartate (NMDA)-evoked, but not KCl-evoked, [3H] acetylcholine release from slices of the rat striatum.
  16. RAGE Antagonist

    FPS-ZM1 inhibits A??40- and A??42-induced cellular stress in RAGE-expressing cells.
  17. γ-secretase inhibitor

    L-685458 is a specific and potent inhibitor of A beta PP gamma-secretase activity with Ki of 17 nM.
  18. COX inhibitor

    Xanthohumol, a prenylated chalcone from hop, inhibits COX-1 and COX-2 activity and shows chemopreventive effects.
  19. GABA(A) modulator

    CTP354 a novel deuterated subtype-selective GABA(A) modulator.
  20. nAChR agonist

    GTS-21 dihydrochloride is a selective α7 nicotinic acetylcholine receptor agonist, has recently been established as a promising treatment for inflammation.
  21. muscarinic receptor antagonist

    Revefenacin is potent and selective muscarinic receptor antagonist in development for the treatment of COPD.
  22. Fenbufen is an orally active phenylalkanoic derivative with anti-inflammatory, analgesic and antipyretic activity.
  23. P2X7 receptor antagonist

    A-804598 is a P2X7 selective, competitive antagonist with the IC50s value for human, rat and mouse channels of 11, 10 and 9 nM, respectively.
  24. NMDA receptors blocker

    Ro 25-6981 Maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit. IC50 values are 0.009 and 52 uM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively.
  25. Methylthioadenosine is a naturally occurring sulfur-containing nucleoside present in all mammalian tissues.
  26. AMPA/kainate antagonist

    CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors, respectively, versus IC50 = 25 uM for NMDA receptors).
  27. β-secretase/BACE1 inhibitor

    Verubecesta is a potent and selective beta-secretase inhibitor, and BACE1 protein inhibitor or Beta-site APP-cleaving enzyme 1 inhibitor.
  28. GABA reuptake inhibitor

    Tiagabine is an anti-convulsive medication. The medication is also utilized in the treatment of panic disorder, as are a few other anticonvulsants.
  29. P2Y12 antagonist

    Prasugrel is a thienopyridine ADP receptor (P2Y12) antagonist, used for the reduction of thrombotic cardiovascular events.
  30. COX inhibitor

    Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity.
  31. GABA receptor agonist

    Piperazine is an organic compound that consists of a six-membered ring containing two nitrogen atoms at opposite positions in the ring.
  32. γ-Secretase modulator

    CHF5074 is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 uM, respectively.
  33. γ-Secretase inhibitor

    Z-Ile-Leu-aldehyde is a potent gamma-Secretase inhibitor; Notch signaling inhibitor.
  34. PKD Inhibitor

    CRT-0066101, potent inhibitor of protein kinase D (PKD); inhibits all PKD isoforms (IC50 values are 1, 2 and 2.5 nM for PKD1, PKD3 and PKD2 respectively).
  35. GABAA receptor ligand

    U-93631 is a GABAA receptor ligand of novel chemical structure with IC50 of 100 nM,and has been shown to induce a rapid, time-dependent decay of GABA-induced whole-cell Cl-currents in recombinant GABAA receptors.
  36. CaMKK inhibitor

    STO-609 is a cell-permeable inhibitor of calcium/calmodulin-dependent kinase kinases (CaMKK) isoforms CaMKKα and CaMKKβ (Ki = 80 and 15 ng/ml, respectively).
  37. Acetylcholine iodide is a neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
  38. COX inhibitor

    Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety. The IC50 values for COX1 and COX2 is 250 nM and 150 nM, respectively.
  39. Amoxapine is a tricyclic dibenzoxazepine (an N-aryl piperazine) which acts similarly to several other tricyclic antidepressants, amoxapine inhibits GLYT2a transport activity with IC50 of 92 μM.
  40. COX inhibitor

    Ampiroxicam is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory drug.
  41. COX-2 inhibitor

    Carprofen reduces inflammation by inhibition of COX-2 and other sources of inflammatory prostaglandins, does not interfere with COX-1 activity.
  42. Choline bitartrate is a form of the nutrient choline which is found in foods.
  43. Choline chloride is a quaternary ammonium salt used as an additive for animal feed.
  44. iron-chelating drug

    Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload.
  45. COX inhibitor

    Diclofenac diethylamine is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor.
  46. Diphemanil methylsulfate is a quaternary ammonium anticholinergic.
  47. nonsteroidal, anti-inflammatory antiarthritic agent

    Fenoprofen Calcium hydrate is a nonsteroidal, anti-inflammatory antiarthritic agent.
  48. 5-HT1A receptor antagonist/COMT inhibitor

    Flopropione is a 5-HT1A receptor antagonist and also a catechol-o-methyltransferase (COMT) inhibitor.

Items 251-300 of 576

per page
Set Descending Direction